Pulp Capping in Primary Molars Using TheraCal (LC)

Ain Shams University

Status and phase: Completed; Phase 4

Conditions: Decayed Teeth; Direct Pulp Capping; Indirect Pulp Capping; Reversible Pulpitis; Vital Pulp Therapy; Deep Caries

Treatments: Drug: Light cured tri-calcium silicate base material

Study type: Interventional

Funder types: Other

Identifiers

NCT05167123

FDASU-RECIM041919

Details and patient eligibility

About

A randomized clinical trial that aims to evaluate clinical and radiographic success rates of indirect pulp capping and direct pulp capping in primary molars with reversible pulpitis using a light-cured tri-calcium silicate base material (TheraCal (LC)).

Full description

Participating primary molars will be randomly allocated to one of the following groups: Indirect pulp capping group or Direct pulp capping group. A light-cured tri-calcium silicate base material (TheraCal (LC) ) will be used in the two groups as a dressing material. Patients will be recruited from the outpatient clinic of the pediatric dentistry department, Faculty of Dentistry Ain Shams University. The participant will be recalled for follow-up assessments at 3, 6,9, and 12 months.

Enrollment: 40 patients

Sex: All

Ages: 4 to 7 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Age: 4-7 years.
2. Free medical history.
3. Complete physical and mental health.
4. Patient cooperation
5. restorable mandibular primary molars

Exclusion criteria

1. Clinical symptoms or irreversible pulpitis as (spontaneous pain, throbbing pain)
2. Soft tissue swelling, draining fistula or sinus tracts.
3. Tenderness to percussion.
4. Pathological Tooth mobility.
5. Widening of periodontal membrane space

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

40 participants in 2 patient groups

Indirect Pulp Capping

Experimental group

Description:

TheraCal (LC) will be applied to affected dentin after excavation of infected dentin

Treatment:

Drug: Light cured tri-calcium silicate base material

Direct Pulp Capping

Experimental group

Description:

TheraCal (LC) will be applied to pinpoint pulp exposures (less than 1mm ) in vital pulps surrounded by sound dentin.

Treatment:

Drug: Light cured tri-calcium silicate base material